Jump Financial’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-516,633
Closed -$9.35M 2272
2026
Q1
$9.35M Sell
516,633
-6,999
-1% -$133K 0.12% 190
2025
Q4
$11.4M Buy
523,632
+120,421
+30% +$3.45M 0.14% 177
2025
Q3
$13.1M Buy
403,211
+303,008
+302% +$11.2M 0.16% 164
2025
Q2
$3.56M Buy
100,203
+52,262
+109% +$1.69M 0.04% 527
2025
Q1
$1.63M Sell
47,941
-102,241
-68% -$3.67M 0.02% 647
2024
Q4
$4.89M Buy
150,182
+143,382
+2,109% +$5.94M 0.1% 262
2024
Q3
$331K Sell
6,800
-39,354
-85% -$2.1M 0.01% 1267
2024
Q2
$2.04M Buy
46,154
+20,113
+77% +$928K 0.04% 546
2024
Q1
$1.46M Sell
26,041
-95,440
-79% -$5.76M 0.04% 593
2023
Q4
$7.31M Buy
121,481
+74,272
+157% +$4.71M 0.23% 64
2023
Q3
$3.17M Buy
47,209
+1,274
+3% +$88.5K 0.12% 220
2023
Q2
$3.17M Buy
+45,935
New +$3M 0.12% 230
2023
Q1
Sell
-47,100
Closed -$2.35M 1832
2022
Q4
$2.35M Sell
47,100
-37,200
-44% -$1.8M 0.12% 224
2022
Q3
$3.44M Buy
+84,300
New +$3.96M 0.13% 223
2022
Q2
Sell
-34,893
Closed -$1.27M 1829
2022
Q1
$1.27M Buy
+34,893
New +$1.38M 0.05% 438
2021
Q4
Sell
-41,116
Closed -$2.08M 1571
2021
Q3
$2.08M Buy
41,116
+5,916
+17% +$246K 0.15% 139
2021
Q2
$1.45M Buy
+35,200
New +$1.2M 0.14% 190

Other funds holding LEGN

Jump Financial's LEGN Position: Q2 2026 in Review

Jump Financial sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 516,633 shares — an estimated $9.35M sold.

Jump Financial first reported a position in LEGN in Q2 2021 and held it in 17 quarters. The position peaked at $13.1M in Q3 2025. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Jump Financial reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 516,633 Legend Biotech shares in Q2 2026, an estimated $9.35M.
  • Jump Financial first reported a position in Legend Biotech in Q2 2021 and held it in 17 quarters.
  • Jump Financial's Legend Biotech position peaked at $13.1M in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.